EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Role of C- Reactive Protein (CRP) and Neutrophil Lymphocyte Ratio (NLR) in detecting severity & Predicting outcome of Acute Pancreatitis patients

Abdul Mumin, A.K.M. Shahriar Kabir, Rifat Ara Noor, Urmi Rahman, Abdullah Al Amin

Dinkum Journal of Medical Innovations · 2024

DOI: 10.71017/djmi.3.1.d-0236 ↗
AbstractBibliografische Angaben

Abstract

Acute pancreatitis is an inflammatory disease with varied clinical course. It may vary from mild to severe. Early identification of potentially severe acute pancreatitis is of utmost importance. Acute pancreatitis patients with delayed transfer to intensive care have higher mortality. The severity of the illness can be assessed by some early clinical features, bed side scoring systems, or by the CT severity index. But all these have own disadvantages. So a single and cost effective laboratory test is desired to predict severity of the disease. This study determined the predicting value of C-reactive protein (CRP) and Neutrophil-Lymphocyte ratio (NLR) for the severity of acute pancreatitis of Acute Pancreatitis patients admitted in Chittagong Medical College Hospital. The study followed the observational cross-sectional study design where data has been collected from N=40 patient of department of medicine, Chittagong Medical College Hospital, Chattogram. After obtaining data from clinical examination and laboratory investigations the enrolled patients were grouped into mild and severe pancreatitis using BISAP score. Patients with BISAP score 3 or >3 were grouped as severe and those who scored 90 mg/L level (20%), which is statistically significant (P value

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →